Dynatronics Corporation (NASDAQ: DYNT) is one of 87 publicly-traded companies in the “Advanced Medical Equipment & Technology” industry, but how does it contrast to its rivals? We will compare Dynatronics Corporation to similar businesses based on the strength of its profitability, risk, valuation, analyst recommendations, dividends, institutional ownership and earnings.

Insider & Institutional Ownership

17.5% of Dynatronics Corporation shares are owned by institutional investors. Comparatively, 51.0% of shares of all “Advanced Medical Equipment & Technology” companies are owned by institutional investors. 51.8% of Dynatronics Corporation shares are owned by insiders. Comparatively, 18.7% of shares of all “Advanced Medical Equipment & Technology” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Earnings & Valuation

This table compares Dynatronics Corporation and its rivals gross revenue, earnings per share and valuation.

Gross Revenue NetIncome Price/Earnings Ratio
Dynatronics Corporation $35.76 million -$1.86 million -1.94
Dynatronics Corporation Competitors $2.13 billion $221.25 million -29.08

Dynatronics Corporation’s rivals have higher revenue and earnings than Dynatronics Corporation. Dynatronics Corporation is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Risk & Volatility

Dynatronics Corporation has a beta of -0.14, indicating that its share price is 114% less volatile than the S&P 500. Comparatively, Dynatronics Corporation’s rivals have a beta of 1.52, indicating that their average share price is 52% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Dynatronics Corporation and its rivals, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Dynatronics Corporation 0 0 0 0 N/A
Dynatronics Corporation Competitors 277 1896 3390 108 2.59

As a group, “Advanced Medical Equipment & Technology” companies have a potential downside of 6.92%. Given Dynatronics Corporation’s rivals higher probable upside, analysts plainly believe Dynatronics Corporation has less favorable growth aspects than its rivals.

Profitability

This table compares Dynatronics Corporation and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Dynatronics Corporation -5.47% -88.57% -9.59%
Dynatronics Corporation Competitors -299.27% -35.18% -12.46%

Summary

Dynatronics Corporation rivals beat Dynatronics Corporation on 6 of the 9 factors compared.

Dynatronics Corporation Company Profile

Dynatronics Corporation is a manufacturer and distributor of physical medicine products. The Company’s products include a line of medical equipment for physical medicine applications, including therapy devices, medical supplies and soft goods, treatment tables and rehabilitation equipment. Its products are used by physical therapists, chiropractors, sports medicine practitioners, podiatrists, physicians and other physical medicine professionals. Its physical medicine products include therapeutic modalities, such as Dynatron Solaris, including electrotherapy and thermal therapy, and 25 Series, including electrotherapy and ultrasound; manufactured capital products, including traction systems and wood furniture; manufactured supplies, including cold packs, straps, wedges, bolsters and mats; distributed capital products, including hydrotherapy, weight training equipment and pilates, and distributed supplies, including clinical accessories, sports med and taping products, lotions and gels.

Receive News & Ratings for Dynatronics Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics Corporation and related companies with MarketBeat.com's FREE daily email newsletter.